Transplant recipients, especially those with chronic immunosuppression, are at higher risk for severe infections like COVID-19, leading researchers to study this group specifically.
The study involved 25 hospitalized African American renal transplant recipients who tested positive for SARS-CoV-2, focusing on their symptoms, lab results, management strategies, and outcomes.
Despite complications, such as low oxygen saturation and the need for ICU care for some patients, the overall mortality rate in this cohort was low at 4%, suggesting better outcomes compared to other studies involving COVID-19 in transplant patients.